ATE331039T1 - Feststellung von endometriumkrebs - Google Patents
Feststellung von endometriumkrebsInfo
- Publication number
- ATE331039T1 ATE331039T1 AT98909221T AT98909221T ATE331039T1 AT E331039 T1 ATE331039 T1 AT E331039T1 AT 98909221 T AT98909221 T AT 98909221T AT 98909221 T AT98909221 T AT 98909221T AT E331039 T1 ATE331039 T1 AT E331039T1
- Authority
- AT
- Austria
- Prior art keywords
- endometrial cancer
- detection
- matrix metalloproteinase
- assaying
- qualitative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
- G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
- G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPO5736A AUPO573697A0 (en) | 1997-03-20 | 1997-03-20 | Diagnosis of endometrial cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE331039T1 true ATE331039T1 (de) | 2006-07-15 |
Family
ID=3800039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98909221T ATE331039T1 (de) | 1997-03-20 | 1998-03-20 | Feststellung von endometriumkrebs |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6607894B1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP0979304B1 (cg-RX-API-DMAC10.html) |
| JP (2) | JP4183757B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR20010006344A (cg-RX-API-DMAC10.html) |
| CN (1) | CN1257550A (cg-RX-API-DMAC10.html) |
| AT (1) | ATE331039T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AUPO573697A0 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2284099C (cg-RX-API-DMAC10.html) |
| DE (1) | DE69835010T2 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2268767T3 (cg-RX-API-DMAC10.html) |
| MY (1) | MY119567A (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ337868A (cg-RX-API-DMAC10.html) |
| WO (1) | WO1998042865A1 (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA982403B (cg-RX-API-DMAC10.html) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999045147A1 (en) * | 1998-03-05 | 1999-09-10 | Diadexus Llc | A novel method of detecting and monitoring endometrial and uterine cancers |
| AUPQ219799A0 (en) | 1999-08-13 | 1999-09-02 | R. Lurie Pty Ltd | Apparatus for obtaining potological samples |
| US7094754B2 (en) | 2001-08-16 | 2006-08-22 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
| US7186693B2 (en) | 2001-08-16 | 2007-03-06 | Kimberly - Clark Worldwide, Inc. | Metalloproteinase inhibitors for wound healing |
| US6906036B2 (en) | 2001-08-16 | 2005-06-14 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
| US7071164B2 (en) | 2001-08-16 | 2006-07-04 | Kimberly-Clark Worldwide, Inc. | Anti-cancer and wound healing compounds |
| DE10217677A1 (de) | 2002-04-19 | 2003-11-06 | Bayer Ag | Verwendung von Aufhellern zur Herstellung von Streichmassen |
| US7148194B2 (en) | 2002-12-30 | 2006-12-12 | Kimberly-Clark Worldwide, Inc. | Method to increase fibronectin |
| US7189700B2 (en) | 2003-06-20 | 2007-03-13 | Kimberly-Clark Worldwide, Inc. | Anti-chrondrosarcoma compounds |
| US20050112622A1 (en) * | 2003-08-11 | 2005-05-26 | Ring Brian Z. | Reagents and methods for use in cancer diagnosis, classification and therapy |
| US20060003391A1 (en) * | 2003-08-11 | 2006-01-05 | Ring Brian Z | Reagents and methods for use in cancer diagnosis, classification and therapy |
| EP1782068B1 (en) * | 2004-07-23 | 2010-04-07 | Centre de Recherche Public de la Santé | Monitoring heart failure |
| US20080131916A1 (en) * | 2004-08-10 | 2008-06-05 | Ring Brian Z | Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy |
| WO2006086730A2 (en) * | 2005-02-09 | 2006-08-17 | Genentech, Inc. | Inhibiting her2 shedding with matrix metalloprotease antagonists |
| US7504225B2 (en) * | 2005-05-12 | 2009-03-17 | Applied Genomics, Inc. | Reagents and methods for use in cancer diagnosis, classification and therapy |
| RU2304782C1 (ru) * | 2005-12-28 | 2007-08-20 | Государственное образовательное учреждение высшего профессионального образования Московская медицинская академия им. И.М. Сеченова | Способ прогнозирования рецидива эндометриоидной кисты яичника |
| EP2205642B1 (en) | 2007-11-02 | 2016-01-27 | Momenta Pharmaceuticals, Inc. | Non-anticoagulant polysaccharide compositions |
| US8592393B2 (en) | 2007-11-02 | 2013-11-26 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
| US8569262B2 (en) | 2007-11-02 | 2013-10-29 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
| DK2419736T3 (da) * | 2009-04-16 | 2014-04-22 | Momenta Pharmaceuticals Inc | Fremgangsmåder til vurdering af aktivitet af en polysaccharidsammensætning |
| CN105132529A (zh) * | 2009-07-24 | 2015-12-09 | 吉第克生物技术有限公司 | 子宫内膜癌的标记物 |
| BR112012026542A2 (pt) | 2010-04-16 | 2016-07-12 | Momenta Pharmaceuticals Inc | abordagem seletiva de tecido |
| RU2430371C1 (ru) * | 2010-04-26 | 2011-09-27 | Учреждение Российской академии наук Институт ядерной физики им. Г.И. Будкера Сибирского отделения РАН (ИЯФ СО РАН) | Способ дифференциальной диагностики и прогноза миомы и рака эндометрия |
| AU2011268470B2 (en) | 2010-06-17 | 2017-02-02 | Momenta Pharmaceuticals, Inc. | Methods and compositions for promoting hair growth |
| CA2838053A1 (en) * | 2011-06-03 | 2012-12-06 | University Of South Alabama | Methods and compositions for detecting endometrial or ovarian cancer |
| CN107389936A (zh) * | 2011-09-22 | 2017-11-24 | 斯隆-凯特林纪念癌症中心 | 检测卵巢癌 |
| HRP20181726T1 (hr) * | 2012-01-31 | 2018-12-28 | SPEISER, Paul | Neinvazivno dijagnosticiranje raka |
| US10016449B2 (en) | 2013-05-28 | 2018-07-10 | Momenta Pharmaceuticals, Inc. | Pharmaceutical compositions |
| AU2015283811A1 (en) * | 2014-07-02 | 2017-02-09 | Bionomics Limited | Predictive biomarkers |
| CA2975737A1 (en) * | 2015-02-06 | 2016-08-11 | Quest Diagnostics Investments Llc | Compositions and methods for determining endometrial cancer prognosis |
| PT3452829T (pt) * | 2016-05-04 | 2024-03-22 | Fundacio Hospital Univ Vall Dhebron Institut De Recerca | Perm como marcador de cancro endometrial |
| IN202021002695A (cg-RX-API-DMAC10.html) | 2020-01-21 | 2021-07-23 | ||
| CN112961921B (zh) * | 2021-03-26 | 2022-07-01 | 中国医学科学院北京协和医院 | 一种用于判断早期子宫内膜癌预后的制剂及复发风险模型 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5280106A (en) * | 1988-05-20 | 1994-01-18 | Liotta Lance A | Matrix metalloproteinase peptides: role in diagnosis and therapy |
| US5324634A (en) * | 1992-03-31 | 1994-06-28 | The Research Foundation Of State University Of New York | Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer |
| WO1994005807A1 (en) * | 1992-08-28 | 1994-03-17 | Dickson Robert B | Matrix-degrading metalloproteinase |
| JPH09503901A (ja) * | 1992-11-16 | 1997-04-22 | キャンサー リサーチ ファンド オブ コントラ コスタ | 広範な新生物特異性を有するペプチドおよびアンチセンスペプチド |
-
1997
- 1997-03-20 AU AUPO5736A patent/AUPO573697A0/en not_active Abandoned
-
1998
- 1998-03-20 DE DE69835010T patent/DE69835010T2/de not_active Expired - Lifetime
- 1998-03-20 MY MYPI98001218A patent/MY119567A/en unknown
- 1998-03-20 EP EP98909221A patent/EP0979304B1/en not_active Expired - Lifetime
- 1998-03-20 CN CN98805312A patent/CN1257550A/zh active Pending
- 1998-03-20 ZA ZA982403A patent/ZA982403B/xx unknown
- 1998-03-20 JP JP54453698A patent/JP4183757B2/ja not_active Expired - Fee Related
- 1998-03-20 NZ NZ337868A patent/NZ337868A/en not_active IP Right Cessation
- 1998-03-20 WO PCT/AU1998/000189 patent/WO1998042865A1/en not_active Ceased
- 1998-03-20 US US09/381,454 patent/US6607894B1/en not_active Expired - Fee Related
- 1998-03-20 KR KR1019997009429A patent/KR20010006344A/ko not_active Withdrawn
- 1998-03-20 CA CA2284099A patent/CA2284099C/en not_active Expired - Fee Related
- 1998-03-20 ES ES98909221T patent/ES2268767T3/es not_active Expired - Lifetime
- 1998-03-20 AT AT98909221T patent/ATE331039T1/de not_active IP Right Cessation
-
2007
- 2007-01-09 JP JP2007001867A patent/JP2007202556A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| MY119567A (en) | 2005-06-30 |
| WO1998042865A1 (en) | 1998-10-01 |
| EP0979304A4 (en) | 2003-06-11 |
| ES2268767T3 (es) | 2007-03-16 |
| AUPO573697A0 (en) | 1997-04-10 |
| DE69835010D1 (de) | 2006-08-03 |
| EP0979304B1 (en) | 2006-06-21 |
| JP2002501613A (ja) | 2002-01-15 |
| JP4183757B2 (ja) | 2008-11-19 |
| DE69835010T2 (de) | 2007-06-06 |
| US6607894B1 (en) | 2003-08-19 |
| NZ337868A (en) | 2002-05-31 |
| CN1257550A (zh) | 2000-06-21 |
| CA2284099A1 (en) | 1998-10-01 |
| KR20010006344A (ko) | 2001-01-26 |
| EP0979304A1 (en) | 2000-02-16 |
| JP2007202556A (ja) | 2007-08-16 |
| ZA982403B (en) | 1998-10-21 |
| CA2284099C (en) | 2010-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69835010D1 (de) | Feststellung von endometriumkrebs | |
| ATE376187T1 (de) | Nachweis von erkrankungen der nieren und behandlung | |
| ATE291583T1 (de) | Polymorphismus von mononukleotiden und ihre verwendung in der genanalyse | |
| FI953445A0 (fi) | Menetelmä nukleiinihappojen herkkään osoitukseen | |
| DK0749325T3 (da) | Bispecifikke molekyler med klinisk anvendelse | |
| IL109817A0 (en) | Improved method and analytical system for performing fibrinogen assays accurately, rapidly and simply | |
| WO2003048300A3 (en) | Methods of identifying cellular target molecules | |
| DK0950113T3 (da) | Detektion af genetisk prædisposition for synstruende diabetisk retinopati | |
| ES2118062T3 (es) | Composiciones reactivas, metodos y reactivos para la valoracion cuantitativa de magnesio o de calcio y magnesio. | |
| ATE107705T1 (de) | Test zur feststellung der empfänglichkeit für dns-assoziierte krankheiten. | |
| ATE80734T1 (de) | Diagnostisches testverfahren eines inhibitors von plasminogen aktivatoren vom tissue- und urokinasetyp. | |
| FI946127A7 (fi) | Menetelmä alukkeen pidentämiseksi yhdellä nukleotidilla spesifisten al leelien detektoimiseksi, ja testipakkaus näiden menetelmien suorittami seksi | |
| ES516987A0 (es) | Un procedimiento para la determinacion cuantitativa del factor xii de coagulacion de la sangre en el plasma sanguineo humano. | |
| IL81695A (en) | Quantitative determination of the degree of amplification of genes and/or corresponding messenger rna and reagent kit for performing the determination | |
| ES2154736T3 (es) | Metodo de analisis. | |
| ATE199025T1 (de) | Test zur diagnose eines erhöhten brustkrebs- risikos | |
| DK0791073T3 (da) | Analysemetode | |
| GB9604305D0 (en) | Diagnostic method and apparatus | |
| ATE213279T1 (de) | Diagnoseverfahren und vorrichtung zum nachweis der prädisposition zu bestimmten krankheitszuständen, insbesondere osteoporose, auf basis von il-6 genpolymorphismus | |
| EP1141703A4 (en) | METHODS FOR DETERMINING INCREASED RISK FOR A WOMAN CARRYING A FETUS WITH DOWN SYNDROME | |
| ATE270345T1 (de) | Nukleinsaeure erkennung von hepatitis gb virus | |
| ES2149448T3 (es) | Agentes terapeuticos y analiticos. | |
| BR9708256A (pt) | Processo para identificar genes com expresão específica ao síto ou de síto preferido em células de marcacção específicas presentes em um ambiente de células diferente ou não daquele de sua origem e uso do mesmo | |
| BR9007895A (pt) | Construcao parc 117,construcao parc 145,construcao parc 1153,fragmento de dna,sonda de hibridizacao,processo para detectar p.vivax em uma amostra biologica de vertebrados ou invertebrados,e processo para a preparacao de uma sonda de hibridizacao | |
| RU97108123A (ru) | Способ выявления "группы опухолевого риска" и скрининга ранних стадий опухолевых заболеваний |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |